Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma
Status:
Completed
Trial end date:
2016-02-17
Target enrollment:
Participant gender:
Summary
Assess the therapeutic activity and safety of the combination of Chlorambucil and Rituximab
in MALT lymphomas and determine whether the addition of Rituximab to Chlorambucil will
improve the outcome of MALT lymphoma in comparison to treatment with Chlorambucil alone.
In April 2006, a third arm of treatment was added to compare the antitumor activity and
safety of rituximab alone vs chlorambucil alone
Phase:
Phase 3
Details
Lead Sponsor:
International Extranodal Lymphoma Study Group (IELSG)